Mithila Samachar

Vasomotor Symptoms of Menopause Emerging Drugs, 2020

 Breaking News
  • No posts were found

Vasomotor Symptoms of Menopause Emerging Drugs, 2020

July 27
23:40 2020
Vasomotor Symptoms of Menopause Emerging Drugs, 2020

DelveInsight Business Research LLP
“Vasomotor Symptoms of Menopause Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Vasomotor Symptoms of Menopause market. A detailed picture of the Vasomotor Symptoms of Menopause pipeline landscape is provided, which includes the disease overview and Vasomotor Symptoms of Menopause treatment guidelines.

Vasomotor Symptoms (VMS) are one of the major symptoms of menopause that principally includes hot flashes (HF) and night sweats (NS) during menopause and occurs in majority of women across the globe. A woman with VMS, experiences abundant heat accompanied by sweating and flushing, especially around head, neck, chest, and upper back region. VMS results from temperature dysfunction that occurs due to changes in gonadal hormones.

 

Scope of Vasomotor Symptoms Report

  • The Vasomotor Symptoms of Menopause report provides an overview of therapeutic pipeline activity and therapeutic assessment of the products by development stage, product type, route of administration, molecule type, and MOA type for Vasomotor Symptoms of Menopause across the complete product development cycle, including all clinical and nonclinical stages.
  • It comprises of detailed profiles of Vasomotor Symptoms of Menopause therapeutic products with key coverage of developmental activities, including technology, collaborations, licensing, mergers and acquisition, funding, designations and other product-related details
  • Detailed Vasomotor Symptoms of Menopause research and development progress and trial details, results wherever available, are also included in the pipeline study.
  • Coverage of dormant and discontinued pipeline projects along with the reasons if available across Vasomotor Symptoms of Menopause.

 

Night sweats are Hot Flashes that occur with heavy perspiration during sleep and cause sleep disruption. Women experiencing night sweats have greater motor restlessness in bed, less efficient sleep and a reduced feeling of restlessness in the morning compared to women without these symptoms.

Drugs covered
1. Donesta
2. NT-814
3. FP-101
4. Fezolinetant
5. SJX 653
6. MT-8554
And many others

The key players in Vasomotor Symptoms market are:
1. Mithra Pharmaceuticals (Donesta Biosciences)
2. KaNDy Therapeutics
3. Fervent Pharmaceuticals
4. Astellas Pharma
5. Sojournix
6. Mitsubishi Tanabe Pharma
And many others

Request for sample pages
Table of contents

1. Report Introduction

2. Vasomotor Symptoms of Menopause 

2.1. Overview

2.2. History 

2.3. Vasomotor Symptoms of Menopause Symptoms

2.4. Causes

2.5.Pathophysiology

2.6. Vasomotor Symptoms of Menopause Diagnosis 

2.6.1. Diagnostic Guidelines

3. Vasomotor Symptoms of Menopause Current Treatment Patterns

3.1. Vasomotor Symptoms of Menopause Treatment Guidelines

4. Vasomotor Symptoms of Menopause – DelveInsight’s Analytical Perspective

4.1. In-depth Commercial Assessment

4.1.1. Vasomotor Symptoms of Menopause companies collaborations, Licensing, Acquisition -Deal Value Trends

4.1.1.1. Assessment Summary

4.1.2. Vasomotor Symptoms of Menopause Collaboration Deals

4.1.2.1. Company-Company Collaborations (Licensing / Partnering) Analysis

4.1.2.2. Company-University Collaborations (Licensing / Partnering) Analysis

4.1.2.3. Vasomotor Symptoms of Menopause Acquisition Analysis

5. Therapeutic Assessment

5.1. Clinical Assessment of Pipeline Drugs 

5.1.1. Assessment by Phase of Development

5.1.2. Assessment by Product Type (Mono / Combination)

5.1.2.1. Assessment by Stage and Product Type

5.1.3. Assessment by Route of Administration

5.1.3.1. Assessment by Stage and Route of Administration

5.1.4. Assessment by Molecule Type

5.1.4.1. Assessment by Stage and Molecule Type

5.1.5. Assessment by MOA

5.1.5.1. Assessment by Stage and MOA

5.1.6. Assessment by Target

5.1.6.1. Assessment by Stage and Target

6. Vasomotor Symptoms of Menopause Late Stage Products (Phase-III)

7. Vasomotor Symptoms of Menopause Mid Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Vasomotor Symptoms of Menopause Discontinued Products

13. Vasomotor Symptoms of Menopause Product Profiles

13.1. Drug Name: Company 

13.1.1. Product Description

13.1.1.1. Product Overview

13.1.1.2. Mechanism of action

13.1.2. Research and Development

13.1.2.1. Clinical Studies

13.1.3. Product Development Activities

13.1.3.1. Collaboration

13.1.3.2. Agreements

13.1.3.3. Acquisition 

13.1.3.4. Patent Detail

13.1.4. Tabulated Product Summary

13.1.4.1. General Description Table

Detailed information in the report

14. Vasomotor Symptoms of Menopause Key Companies

15. Vasomotor Symptoms of Menopause Key Products

16. Dormant and Discontinued Products

16.1. Dormant Products

16.1.1. Reasons for being dormant

16.2. Discontinued Products 

16.2.1. Reasons for the discontinuation

17. Vasomotor Symptoms of Menopause Unmet Needs

18. Vasomotor Symptoms of Menopause Future Perspectives

19. Vasomotor Symptoms of Menopause Analyst Review  

20. Appendix

21. Report Methodology

21.1. Secondary Research

21.2. Expert Panel Validation 

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Categories